Lv Wu

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The emerging role of antibody-drug conjugates in EGFR-mutant non-small cell lung cancer with acquired resistance to third-generation EGFR tyrosine kinase inhibitors.

The emerging role of antibody-drug conjugates in EGFR-mutant non-small cell lung cancer with acquired resistance to third-generation EGFR tyrosine kinase inhibitors.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 13, 2025

Prognostic impact and treatment options for EGFR-mutant non-small cell lung cancer with concurrent EGFR amplification.

Prognostic impact and treatment options for EGFR-mutant non-small cell lung cancer with concurrent EGFR amplification.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 03, 2025

Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?-A Case Report.

Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?-A Case Report.

Journal: Thoracic cancer

Published: September 26, 2025

Causal relationship between oral/gut microbiota and lung cancer: a two-sample Mendelian randomization study.

Causal relationship between oral/gut microbiota and lung cancer: a two-sample Mendelian randomization study.

Journal: Discover oncology

Published: July 26, 2025

Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer.

Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer.

Journal: Nature reviews. Clinical oncology

Published: May 05, 2025

An emerging melody composed of the notes from structural variants - Comment on 'The fusion characteristics of RET fusion in pan-cancer among the Chinese population: A comprehensive genomic analysis' by Chen et al.

An emerging melody composed of the notes from structural variants - Comment on 'The fusion characteristics of RET fusion in pan-cancer among the Chinese population: A comprehensive genomic analysis' by Chen et al.

Journal: Translational oncology

Published: May 01, 2025

C1orf116 inhibits acquired resistance to EGFR inhibitors in EGFR mutant lung adenocarcinoma by suppressing the ATM/ATR pathways.

C1orf116 inhibits acquired resistance to EGFR inhibitors in EGFR mutant lung adenocarcinoma by suppressing the ATM/ATR pathways.

Journal: Translational lung cancer research

Published: March 06, 2025

Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions.

Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions.

Journal: Cancers

Published: December 20, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026